Risk factors for coronary heart disease in a population with a high prevalence of obesity and diabetes: A case-control study of the polynesian population of Western Samoa

Journal of Cardiovascular Risk

Volumn 4, Issue 3, 1997, Pages 173-178

  Wahi, Sudhir ^a   Gatzka, Christoph D ^a   Sherrard, Bridget ^a   Simpson, Harrison ^a   Collins, Veronica ^a   Dowse, Gary ^a   Zimmet, Paul ^a   Jennings, Garry ^a   Dart, Anthony M ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

Coronary heart disease; Diabetes; Hypertension; Low density lipoprotein particle size; Obesity; Polynesian; Risk factors; Samoa

Indexed keywords

LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SAMOA; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CORONARY DISEASE; DATA COLLECTION; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; INDEPENDENT STATE OF SAMOA; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; POLYNESIA; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION;

EID: 0030867492     PISSN: 13506277     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043798-199706000-00003     Document Type: Article

References (45)

1. Collins VR, Dowse GK, Toelupe PM, Imo TT, Aloaina FL, Spark RA, et al.: Increasing prevalence of NIDDM in the Pacific island population of Western Samoa over a 13-year period. Diabetes Care 1994, 17:288-296.
2. Galanis DJ, McGarvey ST, Sobal J, Bausserman L, Levinson PD: Relations of body fat and fat distribution to the serum lipid, apolipoprotein and insulin concentrations of Samoan men and women. Int J Obes Relat Metab Disord 1995, 19:731-738.
3. Hunt SC, Williams RR, Adams TD: Biochemical and anthropometric characterization of morbid obesity in a large Utah pedigree. Obes Res 1995, 3(suppl):165-172.
4. Singh AT, Rainwater DL, Haffner SM, VandeBerg JL, Shelledy WR, Moore PH Jr, et al.: Effect of diabetes on lipoprotein size. Arterioscler Thromb Vase Biol 1995, 15:1805-1811.
5. Haffner SM, Mykkanen L, Robbins D: A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects. Diabetologia 1995, 38:1328-1336.
6. Rose G, McCartnez P, Reid DD: Self administration of a questionnaire on chest pain and intermittent claudication. Br J Prevent Soc Med 1977, 31:42-48.
7. Sherrard B, Simpson H, Cameron J, Wahi S, Jennings G, Dart A: LDL particle size in subjects with previously unsuspected coronary heart disease: relationship with other cardiovascular risk markers. Atherosclerosis 1996, 126:277-287.
8. Arterial Hypertension - Report of a WHO Expert Committee. Geneva: WHO; 1978.
9. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979. 28:1039-1057.
10. National Heart Foundation of Australia and Australian Institute of Health: Risk factor prevalence study: survey no 3 1989, cities analysis. Canberra: NHFA and AIH 1991, 176.
11. Egger G: The case for using waist to hip ratio measurements in routine medical checks. Med J Australia 1992, 156:280-285.
12. Rose G, Baxter PJ, Reid DD, McCartney P: Prevalence and prognosis of electrocardiographic findings in middle-aged men. Br Heart J 1978, 40:636-643.
13. Higgins ITT, Kannel WB, Dawber TR: The electrocardiogram in epidemiological studies: reproducibility, validity, and international comparison. Br J Prev Med 1965, 19:53-68.
14. Tuomilehto J, Zimmet P, Li N, Dowse G: ECG abnormalitites in relation to glucose tolerance and other risk factors in men of the developing Pacific nation of Kiribati. Nutr Metab Cardiovasc Dis 1991, 1:195-200.
15. Cook DG, Shaper AG, MacFarlane PW: Using the WHO (Rose) angina questionnaire in cardiovascular epidemiology. Int J Epidemiol 1989, 18:607-613.
16. Stokes J III, Kannel WB, Wolf PA, Cupples LA, D'Agostino RB: The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham study. Circulation 1987, 75 (suppl V):65-73.
17. Pooling Project Research Group: Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. J Chron Dis 1975, 31:201-306.
18. Johnson AL, Cornoni JC, Cassel JC, Tyroler HA, Heyden S, Hames CG: Influence of race, sex, and weight on blood pressure behaviour in young adults. Am J Cardiol 1975, 35:523-530.
19. Tuomilehto J, Li N, Dowse G, Gareeboo H. Chitson P, Fareed D, et al.: The prevalence of coronary heart disease in the multi-ethnic and high diabetes prevalence population of Mauritius. J Intern Med 1993, 233:187-194.
20. Crews DE: Multivariate prediction of total and cardiovascular mortality in an obese Polynesian population. Am J Public Health 1989, 79:982-986.
21. Hubert HB, Feinleib M, McNamara PM, Castelli WP: Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation 1983, 67:968-977.
22. Knuiman JT, West CE, Burema J: Serum total and high density lipoprotein cholesterol concentrations and body mass index in adult men from 13 countries. Am J Epidemiol 1982, 116:631-642.
23. Dowse GK, Gareeboo H, Zimmet PZ, George K, Alberti MM, Tuomilehto J, et al.: High prevalence of NIDOM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes 1990, 39:390-396.
24. Wingard DL, Barrett-Connor EL, Schiedt-Nave C, McPhillips JB: Prevalence of cardiovascular and renal complications in older adults with normal or impaired glucose tolerance or NIDDM. Diabetes Care 1993, 16:1022-1025.
25. Swan JW, Walton C, Godsland IF, Crook D, Oliver MF, Stevenson JC: Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese men. Br Heart J 1994, 71:41-44.
26. Inchiostro S, Bertoli G, Zanette G, Donadon V: Evidence of higher insulin resistance in NIDDM patients with ischaemic heart disease. Diabetologia 1994, 37:597-603.
27. Nosadini R, Manzato E, Solini A, Fioretto P, Brocco E, Zambon S, et al.: Peripheral, rather than hepatic, insulin resistance and atherogenic lipoprotein phenotype predict cardiovascular complications in NIDDM. Eur J Clin Invest 1994, 24:258-266.
28. Prior IAM, Welby TJ, Østbye T, Salmond CE, Stokes YM: Migration and gout: the Tokelau Island migrant study. BMJ 1987, 295:457-461.
29. Miller NE, Miller GJ, Førde OH, Thelle DS, Mjøs OD: The Trømso heart study: high-density lipoprotein and coronary heart disease: a prospective case-control study. Lancet 1977, 8019:965-968.
30. Miller GJ, Miller NE: Plasma high density lipoprotein concentration and development of ischaemic heart disease. Lancet 1975, 7897:16-19
31. Patsch JR, Miesenböck G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, et al.: Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992, 12:1336-1345.
32. Karpe F, Steiner G, Olivecrona T, Carlson LA, Hamsten A: Metabolism of triglyceride-rich lipoproteins during alimentary lipaemia. J Clin Invest 1993, 91:748-758.
33. Simpson HS, Williamson CM, Olivecrona T: Postprandial lipaemia, fenofibrate and coronary artery disease. Atherosclerosis 1990, 85:193-202.
34. Groot PHE, van Stiphout WAHJ, Krauss XH, Jansen H, van Tol A, van Ramshorst E, et al: Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991, 11:653-662.
35. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Kraus RM: Low density lipoprotein subclasses and risk of myocardial infarction. JAMA 1988, 260:1917-1921.
36. Campos H, Genest JJ Jr, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, et al.: Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 1992, 12:187-195.
37. Coresh J, Kwiterovich PO Jr, Smith HH, Bachorik PS: Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res 1993, 34:1687-1697.
38. Freedman DS, Williamson DF, Gunter EW, Byers T: Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I epidemiologic follow-up study. Am J Epidemiol 1995, 141:637-644.
39. Kotake H, Sawada Y, Hoshio A, Shirota K, Tomokuni A, Doi T, et al.: Relation between serum uric acid and angiographically defined coronary artery disease in postmenopausal women. J Med 1992, 23:409-415.
40. Prior IAM, Rose BS: Uric acid, gout and public health in the South Pacific. NZ Med J 1966, 65:295-300.
41. Zimmet PZ, Whitehouse S, Jackson L, Thoma K: High prevalence of hyperuricaemia and gout in an urbanised Micronesian population. BMJ 1978, 1:1237-1239.
42. Balkau B, King H, Zimmet P, Raper LR: Factors associated with the development of diabetes in the Micronesian population of Nauru. Am J Epidemiol 1985, 122:594-605.
43. Frohlich ED: Uric acid. A risk factor for coronary heart disease [editorial]. JAMA 1993, 270:378-379.
44. Cappuccio RP, Strazzullo P, Farinaro E, Trevisan M: Uric acid metabolism and tubular sodium handling. Results from a population-based study. JAMA 1993, 270:354-359.
45. Zavaroni I, Mazza S, Fantuzzi M, Dall'Aglio E, Bonora E, Delsignore R, et al.: Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia. J Intern Med 1993, 234:25-30.